• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白B mRNA编辑酶催化多肽1(APOBEC-1)的过表达导致依赖于系泊序列的混杂RNA编辑。

Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing.

作者信息

Sowden M, Hamm J K, Smith H C

机构信息

Department of Biochemistry, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA.

出版信息

J Biol Chem. 1996 Feb 9;271(6):3011-7. doi: 10.1074/jbc.271.6.3011.

DOI:10.1074/jbc.271.6.3011
PMID:8621694
Abstract

Apolipoprotein B (apoB) RNA editing involves site-specific deamination of a cytidine to a uridine. A mooring sequence, a spacer region, and a regulator region are components of the apoB RNA editing motif of which only the mooring sequence is both necessary and sufficient for editosome assembly and editing. The catalytic component of the editosome is APOBEC-1. In rat hepatoma, stable cell lines, overexpression of APOBEC-1 resulted in 3 6-fold stimulation of the editing efficiency on either rat endogenous apoB RNA or transiently expressed human apoB RNA. In these cell lines, cytidines in addition to the one at the wild type site were edited. The occurrence and efficiency of this "promiscuous" editing increased with increasing expression of APOBEC-1. Promiscuous editing was restricted to cytidines 5' of the mooring sequence and only occurred on RNAs that had been edited at the wild type site. Moreover, RNAs with mutant editing motifs supported high efficiency but low fidelity editing in the presence of high levels of APOBEC-1. This study demonstrates that overexpression of APOBEC-1 can increase the efficiency of site-specific editing but can also result in promiscuous editing.

摘要

载脂蛋白B(apoB)RNA编辑涉及胞嘧啶向尿嘧啶的位点特异性脱氨作用。一个停泊序列、一个间隔区和一个调节区是apoB RNA编辑基序的组成部分,其中只有停泊序列对于编辑体组装和编辑既是必需的也是充分的。编辑体的催化成分是载脂蛋白B mRNA编辑酶催化多肽1(APOBEC-1)。在大鼠肝癌稳定细胞系中,APOBEC-1的过表达导致大鼠内源性apoB RNA或瞬时表达的人apoB RNA的编辑效率提高3至6倍。在这些细胞系中,除了野生型位点的胞嘧啶外,其他胞嘧啶也被编辑。这种“混杂”编辑的发生率和效率随着APOBEC-1表达的增加而增加。混杂编辑仅限于停泊序列5'端的胞嘧啶,并且只发生在野生型位点已被编辑的RNA上。此外,在高水平APOBEC-1存在的情况下,具有突变编辑基序的RNA支持高效率但低保真度的编辑。这项研究表明,APOBEC-1的过表达可以提高位点特异性编辑的效率,但也会导致混杂编辑。

相似文献

1
Overexpression of APOBEC-1 results in mooring sequence-dependent promiscuous RNA editing.载脂蛋白B mRNA编辑酶催化多肽1(APOBEC-1)的过表达导致依赖于系泊序列的混杂RNA编辑。
J Biol Chem. 1996 Feb 9;271(6):3011-7. doi: 10.1074/jbc.271.6.3011.
2
Apolipoprotein B RNA sequence 3' of the mooring sequence and cellular sources of auxiliary factors determine the location and extent of promiscuous editing.停泊序列3'端的载脂蛋白B RNA序列以及辅助因子的细胞来源决定了混杂编辑的位置和程度。
Nucleic Acids Res. 1998 Apr 1;26(7):1644-52. doi: 10.1093/nar/26.7.1644.
3
Hyperediting of multiple cytidines of apolipoprotein B mRNA by APOBEC-1 requires auxiliary protein(s) but not a mooring sequence motif.载脂蛋白B信使核糖核酸的多个胞嘧啶经载脂蛋白B信使核糖核酸编辑酶催化多肽1进行超编辑需要辅助蛋白,但不需要停泊序列基序。
J Biol Chem. 1996 May 10;271(19):11506-10. doi: 10.1074/jbc.271.19.11506.
4
Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing.载脂蛋白B信使核糖核酸中胞嘧啶6666编辑位点两侧的两个效率元件支持系泊依赖性编辑。
J Biol Chem. 1998 Apr 17;273(16):9435-42. doi: 10.1074/jbc.273.16.9435.
5
Disproportionate relationship between APOBEC-1 expression and apolipoprotein B mRNA editing activity.载脂蛋白B mRNA编辑酶催化多肽1(APOBEC-1)表达与载脂蛋白B mRNA编辑活性之间的不均衡关系。
Exp Cell Res. 1999 Oct 10;252(1):154-64. doi: 10.1006/excr.1999.4598.
6
Mutagenesis of apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, reveals distinct domains that mediate cytosine nucleoside deaminase, RNA binding, and RNA editing activity.载脂蛋白B mRNA编辑酶的催化亚基apobec-1的诱变揭示了介导胞嘧啶核苷脱氨酶、RNA结合和RNA编辑活性的不同结构域。
J Biol Chem. 1995 Jun 16;270(24):14768-75.
7
Determinants involved in regulating the proportion of edited apolipoprotein B RNAs.参与调节载脂蛋白B RNA编辑比例的决定因素。
RNA. 1996 Mar;2(3):274-88.
8
Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.鉴定具有不同支持载脂蛋白B mRNA编辑能力的载脂蛋白B mRNA编辑酶催化多肽1互补因子的新型可变剪接变体。
J Biol Chem. 2004 Jan 2;279(1):197-206. doi: 10.1074/jbc.M307920200. Epub 2003 Oct 21.
9
Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor.RNA结合蛋白CUGBP2在哺乳动物RNA编辑中的新作用。CUGBP2通过与载脂蛋白B mRNA的胞嘧啶脱氨酶1(apobec-1)及其互补因子ACF相互作用,调节载脂蛋白B mRNA的C到U编辑。
J Biol Chem. 2001 Dec 14;276(50):47338-51. doi: 10.1074/jbc.M104911200. Epub 2001 Sep 27.
10
Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing.鉴定GRY-RBP作为一种载脂蛋白B RNA结合蛋白,它与载脂蛋白B mRNA编辑酶催化多肽1(apobec-1)和载脂蛋白B mRNA编辑酶催化多肽1互补因子相互作用以调节C到U的编辑。
J Biol Chem. 2001 Mar 30;276(13):10272-83. doi: 10.1074/jbc.M006435200. Epub 2000 Dec 27.

引用本文的文献

1
Deaminase-Driven Reverse Transcription Mutagenesis in Oncogenesis: Critical Analysis of Transcriptional Strand Asymmetries of Single Base Substitution Signatures.脱氨酶驱动的逆转录诱变在肿瘤发生中的作用:单碱基替换特征转录链不对称性的批判性分析
Int J Mol Sci. 2025 Jan 24;26(3):989. doi: 10.3390/ijms26030989.
2
Identification of RBM46 as a novel APOBEC1 cofactor for C-to-U RNA-editing activity.鉴定 RBM46 为 APOBEC1 的新型共因子,具有 C 到 U RNA 编辑活性。
J Mol Biol. 2023 Dec 15;435(24):168333. doi: 10.1016/j.jmb.2023.168333. Epub 2023 Oct 29.
3
The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.
APOBEC 介导的 RNA 编辑在 SARS-CoV-2 突变、复制和适应性中的作用。
Sci Rep. 2022 Sep 13;12(1):14972. doi: 10.1038/s41598-022-19067-x.
4
The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.载脂蛋白B编辑复合体介导的RNA编辑在严重急性呼吸综合征冠状病毒2突变、复制及适应性中的作用
Res Sq. 2022 Apr 12:rs.3.rs-1524060. doi: 10.21203/rs.3.rs-1524060/v1.
5
The Roles of APOBEC-mediated RNA Editing in SARS-CoV-2 Mutations, Replication and Fitness.载脂蛋白B介导的RNA编辑在严重急性呼吸综合征冠状病毒2(SARS-CoV-2)突变、复制及适应性中的作用
bioRxiv. 2022 Apr 7:2021.12.18.473309. doi: 10.1101/2021.12.18.473309.
6
Comprehensive bioinformatics analyses of APOBECs family and identification of APOBEC3D as the unfavorable prognostic biomarker in clear cell renal cell carcinoma.载脂蛋白B mRNA编辑酶催化多肽样蛋白(APOBECs)家族的综合生物信息学分析及APOBEC3D作为透明细胞肾细胞癌不良预后生物标志物的鉴定。
J Cancer. 2021 Oct 17;12(23):7101-7110. doi: 10.7150/jca.61972. eCollection 2021.
7
Mutational spectrum of SARS-CoV-2 during the global pandemic.全球大流行期间 SARS-CoV-2 的突变谱。
Exp Mol Med. 2021 Aug;53(8):1229-1237. doi: 10.1038/s12276-021-00658-z. Epub 2021 Aug 27.
8
In vivo cytidine base editing of hepatocytes without detectable off-target mutations in RNA and DNA.在体肝细胞中的胞嘧啶碱基编辑,在 RNA 和 DNA 中均未检测到脱靶突变。
Nat Biomed Eng. 2021 Feb;5(2):179-189. doi: 10.1038/s41551-020-00671-z. Epub 2021 Jan 25.
9
Molecular origins of APOBEC-associated mutations in cancer.癌症中 APOBEC 相关突变的分子起源。
DNA Repair (Amst). 2020 Oct;94:102905. doi: 10.1016/j.dnarep.2020.102905. Epub 2020 Jul 6.
10
Apobec1 complementation factor (A1CF) and RBM47 interact in tissue-specific regulation of C to U RNA editing in mouse intestine and liver.Apobec1 补体因子 (A1CF) 和 RBM47 在小鼠肠道和肝脏中 C 到 U RNA 编辑的组织特异性调节中相互作用。
RNA. 2019 Jan;25(1):70-81. doi: 10.1261/rna.068395.118. Epub 2018 Oct 11.